AXIM Biotechnologies Buy Hold or Sell Recommendation

AXIM -- USA Stock  

USD 0.80  0.08  9.02%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AXIM Biotechnologies is 'Strong Sell'. Macroaxis provides AXIM Biotechnologies buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AXIM positions. The advice algorithm takes into account all of AXIM Biotechnologies available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AXIM buy-and-hold prospective. Check also AXIM Biotechnologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell AXIM BiotechnologiesBuy AXIM Biotechnologies
Strong Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon AXIM Biotechnologies has a mean deviation of 4.87, semi deviation of 0.0, standard deviation of 7.54, variance of 56.84, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on AXIM Biotechnologies. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available now. To make sure AXIM Biotechnologies is not overpriced, please confirm all AXIM Biotechnologies fundamentals including its Revenue, Cash Flow from Operations, Z Score, as well as the relationship between Cash per Share and Total Asset . As AXIM Biotechnologies appears to be a penny stock we also recommend to validate its Price to Sales numbers.

AXIM Biotechnologies Trading Alerts and Improvement Suggestions

AXIM Biotechnologies generates negative expected return over the last 30 days
AXIM Biotechnologies has high historical volatility and very poor performance
AXIM Biotechnologies has some characteristics of a very speculative penny stock
AXIM Biotechnologies has high likelihood to experience some financial distress in the next 2 years
The company currently holds 5.94M in liabilities with Debt to Equity (D/E) ratio of 1.8 which is about average as compared to similar companies. AXIM Biotechnologies has Current Ratio of 0.85 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
The entity reported previous year revenue of 198.43K. Net Loss for the year was (6.33M) with profit before overhead, payroll, taxes, and interest of 187.1K.
AXIM BIOTECHNOLOGIES currently holds about 2.84M in cash with (4.41M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Roughly 71.0% of AXIM Biotechnologies shares are held by company insiders

AXIM Biotechnologies Returns Distribution Density

Mean Return0.59Value At Risk8.87
Potential Upside9.24Standard Deviation7.54
 Return Density 
      Distribution 

AXIM Biotechnologies Greeks

α
Alpha over DOW
=1.09
β
Beta against DOW=3.26
σ
Overall volatility
=7.69
Ir
Information ratio =0.1

AXIM Biotechnologies Volatility Alert

AXIM Biotechnologies is displaying above average volatility of 7.54 over selected time horizon. Investors should scrutinize AXIM Biotechnologies independently to make sure intended market timing strategies are aligned with expectations about AXIM Biotechnologies volatility. AXIM Biotechnologies is a potential penny stock. Although AXIM Biotechnologies may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in AXIM Biotechnologies. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare AXIM Biotechnologies to competition

AXIM Biotechnologies Fundamental Vs Peers

FundamentalsAXIM BiotechnologiesPeer Average
Return On Equity0.0123% (0.31)%
Return On Asset(171.97)% (0.14)%
Current Valuation54.22M16.62B
Shares Outstanding61.57M571.82M
Shares Owned by Insiders70.54% 10.09%
Price to Earning(53.71)X28.72X
Price to Book19.05X9.51X
Price to Sales257.58X11.42X
Revenue198.43K9.43B
Gross Profit187.1K27.38B
EBITDA(5.3M)3.9B
Net Income(6.33M)570.98M
Cash and Equivalents2.84M2.7B
Cash per Share0.05X5.01X
Total Debt5.94M5.32B
Debt to Equity1.80% 48.70%
Current Ratio0.87X2.16X
Book Value Per Share(0.09)X1.93K
Cash Flow from Operations(4.41M)971.22M
Earnings Per Share(0.11)X3.12X
Number of Employees418.84K
Beta-4.25-0.15
Market Capitalization51.11M19.03B
Total Asset1.26M29.47B
Retained Earnings(4.26M)9.33B
Working Capital(1.36M)1.48B
Current Asset1.18M9.34B
Current Liabilities2.55M7.9B
Z Score-13.88.72
Search macroaxis.com